please can people comment on the reasons why if they wish
I’m trying to see what the views are and why on this matter
Basically the MRC are in talks with the CMRC over a funding proposal for extending the uk biobank and doing genetics research (this is taking a long time ) and have an application from Dr Karl Morten et al they’re being asked to fund to the tune of £1,5m, per year I think that was.
Otherwise the MRC have refused to issue a funding call following on from the one in 2011 , this is different to other countries such as Norway who as well as funding the rituximab trial also issued a significant funding call. From the Gibson inquiry 2006: to the U.K. HOC debate recently, Members of parliament have thought either significant funding should be being put in by the MRC or there should be “more money for biomedical research” which admittedly is quite vague.
I’m trying to see what the views are and why on this matter
Basically the MRC are in talks with the CMRC over a funding proposal for extending the uk biobank and doing genetics research (this is taking a long time ) and have an application from Dr Karl Morten et al they’re being asked to fund to the tune of £1,5m, per year I think that was.
Otherwise the MRC have refused to issue a funding call following on from the one in 2011 , this is different to other countries such as Norway who as well as funding the rituximab trial also issued a significant funding call. From the Gibson inquiry 2006: to the U.K. HOC debate recently, Members of parliament have thought either significant funding should be being put in by the MRC or there should be “more money for biomedical research” which admittedly is quite vague.
Last edited: